Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06521333Completed
Randomised trial of resveratrol 1% gel in Mucogingival defect (3 arms), sponsored by Cairo University. Primary endpoint: Postoperative Pain. Started May 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06521333.